Ocugen is trading 5.05% up at $1.08 on September 29, 2026; no direct catalyst for the intraday gain has been confirmed.
- On September 25, Ocugen announced provisional approval and priority designation in The Bahamas for OCU400, with an expanded-access program planned.
- On September 29, Ocugen announced that executives will participate in upcoming October investor and industry conferences.
- No source found explicitly ties either announcement to the intraday gain.